generated: '2026-08-02'
method: derived
source: >-
  Live probes of https://www.a2bio.com/ and https://www.a2bio.com/wp-json/ on 2026-08-02
summary: >-
  A2 Biotherapeutics is a clinical-stage biotechnology company and does not run an API programme.
  There is no developer portal, no published versioning policy, no deprecation policy, no SLA and no
  status page. What follows records the observable lifecycle posture of the one live API surface —
  the WordPress REST API on the corporate site — and the negative results are as much the finding as
  the positive ones.
versioning:
  scheme: uri-path-namespace
  current: wp/v2
  policy_url: null
  detail: >-
    Version is carried in the namespace segment. The site advertises 16 namespaces, each versioned
    independently: wp/v2, wp-abilities/v1, oembed/1.0, wp-site-health/v1, wp-block-editor/v1, plus
    plugin namespaces. The `mcp` namespace is unversioned. No provider-published versioning policy
    exists; these are WordPress platform conventions.
deprecation:
  policy_url: null
  sunset_header: false
  deprecation_header: false
  detail: >-
    No RFC 8594 Sunset or Deprecation headers were observed on any response, and the provider
    publishes no deprecation policy.
deprecated_operations: []
sla:
  url: null
  uptime_target: null
status_page: null
status_page_probes:
  - {host: 'https://status.a2bio.com/', result: NXDOMAIN}
  - {host: 'https://trust.a2bio.com/', result: NXDOMAIN}
changelog:
  url: null
  detail: >-
    No API changelog. The company's Newsroom (https://www.a2bio.com/newsroom/) is a corporate press
    release feed with an RSS endpoint at https://www.a2bio.com/feed/, not a release-notes surface.
support:
  developer_support: null
  general_contact: https://www.a2bio.com/contact-us/
  media_inquiries: https://www.a2bio.com/newsroom/media-inquiries/
  detail: No developer support channel of any kind — no forum, no community, no support email for API use.
company_stage:
  status: active
  detail: >-
    Clinical-stage; the newsroom carried a press release dated 2026-05-21 reporting efficacy data
    from the EVEREST-2 clinical study, so the company and the site are actively maintained.
  evidence: 'https://www.a2bio.com/wp-json/wp/v2/posts (HTTP 200, 28 posts, most recent 2026-05-21)'
x-evidence:
  fetched: '2026-08-02'